Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

NCT01138124 · clinicaltrials.gov ↗

COMPLETED

Status

54202

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Pelvis Cancer
Restless Legs Syndrome
Epilepsy
Neuropathic Pain
Chronic Pancreatitis
Hypertension
Pancreatic Cancer
Diabetes
Renal Cancer
Renal Cell Carcinoma

Interventions

DRUG: Gabapentin prescriptions

Sponsor

GlaxoSmithKline